Aurobindo Pharma informs about press release

31 Mar 2016 Evaluate

Aurobindo Pharma has informed about a press release dated March 31, 2016 titled ‘Aurobindo Pharma receives USFDA Approval for Pantoprazole Sodium for Injection’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1159.60 -7.60 (-0.65%)
20-Jan-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.00
Dr. Reddys Lab 1185.20
Cipla 1378.40
Zydus Lifesciences 876.90
Lupin 2163.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×